{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["23(10)"],"submitter":["Koren MA"],"funding":["NIAID NIH HHS"],"journal":["The Lancet. Infectious diseases"],"pagination":["1175-1185"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10877583"],"repository":["biostudies-literature"],"pubmed_title":["Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial."],"pmcid":["PMC10877583"],"funding_grant_id":["R01 AI155983"],"pubmed_authors":["Valencia-Ruiz A","Curley JM","Donofrio G","Gromowski GD","Costanzo M","Lee C","Dussupt V","Jarman RG","De La Barrera R","Thomas SJ","Amare MF","Adedeji O","Mebrahtu T","Darden J","Mills KT","Crowell TA","Hamer MJ","Koren MA","Sondergaard EL","Copeland NK","Peel S","Keiser PB","Modjarrad K","Robb ML","Krebs SJ","Hutter JN","Michael NL","Lin L","Eckels KH"],"additional_accession":[]},"is_claimable":false,"name":"Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial.","description":null,"dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Oct","modification":"2026-05-29T11:40:37.519Z","creation":"2025-02-18T23:23:47.494Z"},"accession":"S-EPMC10877583","cross_references":{"pubmed":["37390836"],"doi":["10.1016/S1473-3099(23)00192-5","10.1016/s1473-3099(23)00192-5"]}}